D&O excess insurers in Pfizer claim dispute

Arch Insurance and US Specialty Insurance Company (SIC) are
seeking a judgment from the court of New Jersey to confirm they do
not have to pay out for historic multi-million-dollar shareholder
actions against pharmaceutical giant Pfizer.
According to court documents, the two carriers provided Pfizer
with excess-of-loss (XoL) insurance for side A and side B
directors' and officers' (D&O) towers covering the
2004-2005 policy year.
Pfizer has sought to claim on the policy in connection with a
s